Nowarta110 TopicalVersusPlacebo for the Treatment of Plantar Warts: A Phase I/II Randomized Controlled Clinical Trial

Topical Nowarta110 is a safe, well-tolerated, and highly effective therapeutic modality in treating refractory and recurrent plantar warts. The breakthrough findings of the study encourage further extensive clinical trials to fully explore the prospect of Nowarta110 in managing all types of warts and HPV-related diseases.